| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/02/2007 | WO2007044809A3 Albumin-free botulinum toxin based pharmaceutical compositions containing a hyaluronidase and methods of use |
| 08/02/2007 | WO2007044059A8 Electromagnetic treatment apparatus for augmenting wound repair and method for using same |
| 08/02/2007 | WO2007018607A3 Therapeutic uses of artificial nanostructures |
| 08/02/2007 | WO2007007095A3 Pharmaceutical compositions comprising a tgf-beta superfamily member |
| 08/02/2007 | WO2006138558A3 Cytotoxic ribonuclease variants |
| 08/02/2007 | WO2006133391A3 Improved treatment for anemia using a hif-alpha stabilising agent |
| 08/02/2007 | WO2006130676A3 Inhibition of neuronal damage |
| 08/02/2007 | WO2006128125A3 Methods of and compositions for stimulation of glucose uptake into muscle cells and treatment of diseases |
| 08/02/2007 | WO2006112552A3 Therapeutic agents for abeta related disorders |
| 08/02/2007 | WO2006112551A3 A THERAPEUTIC AGENT FOR Aβ RELATED DISORDERS |
| 08/02/2007 | WO2006078766A3 Methods and compositions for metastatic tumor screening |
| 08/02/2007 | WO2006068867A9 Combination therapy for b cell disorders |
| 08/02/2007 | WO2005089505A3 Detection, isolation and uses of renalase (monoamine oxidase c) |
| 08/02/2007 | WO2005079343A3 Identification and characterization of multiple splice variants of the mu opioid receptor gene |
| 08/02/2007 | WO2005067957A3 Use of a dg147 protein product for preventing and treating metabolic disorders |
| 08/02/2007 | WO2005058062A3 A process for inhibition of proteolytic activity during the ensiling of forages |
| 08/02/2007 | WO2005019264A3 Human lxr alpha variants |
| 08/02/2007 | WO2004033637A3 Extracellular messengers |
| 08/02/2007 | WO2004013292A3 Extracellular messengers |
| 08/02/2007 | WO2004005487A3 Polynucleotides encoding a novel testis-specific tubulin tyrosine-ligase-like protein, bgs42 |
| 08/02/2007 | WO2003029403A3 Targeting proteins to cells expressing mannose receptors via expression in insect cells |
| 08/02/2007 | WO2002062964A3 Ap1 amine oxidase variants |
| 08/02/2007 | US20070180544 Methods and compositions for autism spectrum disorders |
| 08/02/2007 | US20070179283 Extraction process for a pharmaceutical product |
| 08/02/2007 | US20070179281 BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy |
| 08/02/2007 | US20070179278 HIV fusion inhibitor peptides with improved biological properties |
| 08/02/2007 | US20070179192 Thrombopoietin mimetics |
| 08/02/2007 | US20070179179 respiratory diseases such as asthma, chronic obstructive pulmonary disease, bronchitis; useful in the treatment of nervous system injury and premature labor; 1-{2-[N-2-(4-hydroxy-3-formylaminophenyl)-2-(RS) hydroxyethyl]aminoethyl}-4-[N-(2-phenyl-2-(RS)-hydroxyethyl)amino]phenyl; milveterol |
| 08/02/2007 | US20070179160 Use of rnai inhibiting parp activity for the manufacture of a medicament for the treatment of cancer |
| 08/02/2007 | US20070179105 Method and means for treating solid tumors |
| 08/02/2007 | US20070179099 Methods of cholesterol reduction using isoflavones |
| 08/02/2007 | US20070179097 GnRH agonist combination drugs |
| 08/02/2007 | US20070179096 Pharmaceutical Formulation |
| 08/02/2007 | US20070179095 orally administering to a patient a therapeutically effective amount of factor VIII in water to induce oral tolerance and supply exogenous factor VIII ( not present in liposome), for increasing hemostasis in the patient having hemophilia A; obtained from milk of a non-human transgenic mammal |
| 08/02/2007 | US20070179094 Modulation of MDL-1 activity for treatment of inflammatory disease |
| 08/02/2007 | US20070179093 Growth factor modified protein matrices for tissue engineering |
| 08/02/2007 | US20070179092 Method of Enhancing Neural Stem Cell Proliferation, Differentiation, and Survival Using Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) |
| 08/02/2007 | US20070179091 Hedgehog Kinases and Their Use in Modulating Hedgehog Signaling |
| 08/02/2007 | US20070179090 G protein coupled receptor agonists and antagonists and methods of activating and inhibiting G protein coupled receptors using the same |
| 08/02/2007 | US20070179089 Structure of SOCS and uses thereof |
| 08/02/2007 | US20070179088 Foggy |
| 08/02/2007 | US20070179087 Method for treating inflammatory diseases using heat shock proteins |
| 08/02/2007 | US20070179086 Polypeptides and antibodies |
| 08/02/2007 | US20070179085 Modulation of rhamm-caveolin/lipid raft interactions to affect development, responses to tissue injury, angiogenesis, tumorigenesis, metastasis and growth factor/cytokine responses |
| 08/02/2007 | US20070179084 Process for reducing the concentration of blood glucose in a diabetic patient |
| 08/02/2007 | US20070179083 Covalent attachment of ligands to nucleophilic proteins guided by non-covalent binding |
| 08/02/2007 | US20070178572 Protein crystal structure |
| 08/02/2007 | US20070178560 Measuring the energy transfer between fusion proteins comprising a leptin receptor and an energy donor protein ; bone disorders |
| 08/02/2007 | US20070178559 Platelet promoting protein and the usage thereof |
| 08/02/2007 | US20070178553 Mammalian T-type calcium channels |
| 08/02/2007 | US20070178552 Method for Making Multispecific Antibodies Having Heteromultimeric and Common Components |
| 08/02/2007 | US20070178551 Methods for producing modified glycoproteins |
| 08/02/2007 | US20070178540 Goodpasture antigen binding protein |
| 08/02/2007 | US20070178527 Human platelet-derived growth factor receptors |
| 08/02/2007 | US20070178509 kit for the diagnosis or detection of cancer in a mammal; biomarkers for distinguishing between tumors of differing metastatic potential |
| 08/02/2007 | US20070178502 Methods for determining the prognosis for cancer patients using TUCAN |
| 08/02/2007 | US20070178467 Gm1 promoter and use thereof |
| 08/02/2007 | US20070178172 Composition for reducing blood lipids |
| 08/02/2007 | US20070178159 In-Situ Forming Porous Scaffold |
| 08/02/2007 | US20070178155 Preparation for gastric buoyant sustained drug release dosage form |
| 08/02/2007 | US20070178148 Preparations of growth hormone |
| 08/02/2007 | US20070178137 Local control of inflammation |
| 08/02/2007 | US20070178130 Cohesive osteogenic putty and materials therefor |
| 08/02/2007 | US20070178122 Fusion proteins comprising modified allergens of the ns-ltps family, use thereof and pharmaceutical compositions comprising the same |
| 08/02/2007 | US20070178114 Novel kallikrein gene |
| 08/02/2007 | US20070178113 Superantigen conjugate |
| 08/02/2007 | US20070178109 glycoprotein 120; fusion proteins; myelin basic protein; autoimmune diseases; genetic vaccines |
| 08/02/2007 | US20070178108 Colon Specific Gene and Protein and Cancer |
| 08/02/2007 | US20070178105 FHIT proteins and nucleic acids and methods based thereon |
| 08/02/2007 | US20070178097 Interleukin-10 antibodies |
| 08/02/2007 | US20070178094 Autoimmune diseases; antitumor agents; antiallergens; enhancing the immune response of an individual to a specific molecule, by enhancing the MHC class II presentation of an antigenic epitope of the molecule to T lymphocytes of the individual |
| 08/02/2007 | US20070178090 Breast endothelial cell expression patterns |
| 08/02/2007 | US20070178088 Fibronectins; drug screening; treating cardiovascular/nervous system disorders |
| 08/02/2007 | US20070178085 BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy |
| 08/02/2007 | US20070178081 Combination therapy for treating protein deficiency disorders |
| 08/02/2007 | US20070178080 Lecithinized superoxide dismutase composition and a process for its production |
| 08/02/2007 | US20070178077 Method for in vitro preconditioning of myoblasts before transplantation |
| 08/02/2007 | US20070178071 Stem-cell, precursor cell, or target cell-based treatment of multiorgan failure and renal dysfunction |
| 08/02/2007 | US20070178064 Use to enhance apoptosis; antiproliferative agents; IAP (inhibitor-of apoptosis) |
| 08/02/2007 | US20070178063 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 08/02/2007 | US20070178045 Cyclopeptide derivatives with anti-integrin activity |
| 08/02/2007 | DE102006004142A1 Use of colony-stimulating factors for treating or preventing coma and neurotoxicity, including apallic or locked-in syndromes and poisoning by amphetamine derivatives |
| 08/02/2007 | DE102006004008A1 Treating or preventing multiple sclerosis comprises administering erythropoietin for periods separated by intervals in which no erythropoietin is administered |
| 08/02/2007 | DE102006003814A1 Diagnosis of Chlamydophila pneumoniae infection comprises assaying a sample for heat shock protein J or for antibodies directed against this protein |
| 08/02/2007 | CA2650072A1 Recombinant human epo-fc fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo |
| 08/02/2007 | CA2640342A1 Composition containing several botulic toxins |
| 08/02/2007 | CA2640088A1 Compositions and methods for inhibition leukocyte function |
| 08/02/2007 | CA2640087A1 Methods and compositions for modulating the mobilization of stem cells |
| 08/02/2007 | CA2640010A1 Purification and use of a factor for supporting wound healing |
| 08/02/2007 | CA2638773A1 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects |
| 08/02/2007 | CA2637681A1 Asparagine-10-substituted nonadepsipeptides |
| 08/02/2007 | CA2637644A1 Treatment of acute respiratory distress syndrome |
| 08/02/2007 | CA2637295A1 Fgf2-binding peptides and uses thereof |
| 08/02/2007 | CA2636724A1 Adiponectin for treatment of various disorders |
| 08/02/2007 | CA2636426A1 Treatment of ischemic disease using thrombopoietin |
| 08/02/2007 | CA2635498A1 Thrombopoietic compounds |
| 08/02/2007 | CA2622312A1 Combination therapy for the treatment of neovascular disorders |
| 08/01/2007 | EP1813672A2 Transgenic non-human animals capable of producing heterologous antibodies |
| 08/01/2007 | EP1813625A1 Method of modulating the profileration of medullary thyroid carcinoma cells |
| 08/01/2007 | EP1813624A1 Methods and compositions for the prevention and treatment of anemia |